Target intelligence / Profile preview

DNA cross-linking

Molecular classification
Other
01

Overview

DNA cross-linking refers to the formation of covalent bonds between two nucleotides within the same strand (*intrastrand*) or across complementary strands (*interstrand*) in double-stranded DNA. This process can be triggered by exogenous agents such as chemotherapeutic alkylating agents or endogenous metabolic byproducts. Cross-links disrupt essential cellular processes like replication and transcription, often resulting in cell cycle arrest and activation of apoptotic pathways. In cancer therapy, bifunctional alkylating agents exploit this mechanism to selectively kill rapidly dividing tumor cells by overwhelming their repair capacity, ultimately inducing apoptosis[1][2]. However, because "DNA cross-linking leading to apoptosis" describes a **cellular process** rather than a discrete molecular target such as an enzyme or receptor, it is not considered a canonical therapeutic target itself but rather an outcome exploited by certain drugs[2]. If you are seeking structured information for drug targets involved in this pathway—such as specific enzymes responsible for repairing these lesions (e.g., Fanconi anemia proteins) or proteins mediating apoptosis—you should specify those molecules individually. **Note:** The entry "DNA cross-linking leading to apoptosis" is not itself a canonical molecular target but describes a mechanism/process; therefore `is_target` is false and `is_incorrect` is true according to your conventions.

Other names
DNA interstrand cross-linkDNA intrastrand cross-linkDNA-protein cross-linkCrosslinking of DNA
02

Mechanism of action

Induction of covalent bonds between nucleotides on the same or opposite strands of DNA, leading to inhibition of replication/transcription and triggering apoptosis[1][2].

03

Biological functions

Cell deathApoptosisInhibition of DNA replication and transcriptionGenomic instability (if unrepaired)
04

Disease associations

Cancer (as a therapeutic target/process)Other (can contribute to mutagenesis and disease if not repaired)
05

Safety considerations

Off-target toxicity to healthy cells due to non-specific action[1]
06

Interacting drugs

Nitrogen mustards (e.g., mechlorethamine, HN2)

2 more in the full profile.

Beyond the preview

Go deeper on DNA cross-linking.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA cross-linking.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call